News

MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced that an abstract highlighting pre-clinical data on DA-1241, a ...
Cirius Therapeutics, Inc., developing innovative therapies for patients suffering from diseases caused by insulin resistance, ...
The poster presented at the meeting will be made available on the Glucotrack website following the conference.
ILOILO CITY (PIA) — The Regional Scientific Meeting (RSM) held in Iloilo City pushed for collaboration and a call to action ...
Fashion met science recently as an interdisciplinary team of undergraduate fashion merchandising and biochemistry students ...
a Pivotal Validation Study of an AI/ML-Based Software Poster Session: B110 - The road to Early Detection: Advancing Lung Cancer Screening through AI, Risk Models, and Real-World Data About Median ...
International Congress Center, Munich (Messe München) — from June 22 to 27 will kick off with a fresh new design and plenty of first-class speakers. The two-yearly congress in the heart of Europe will ...
Annual event highlights work in public health, cancer, psychology and clinical studies across Puerto Rico. #NewsismyBusiness ...
The following oral presentation will take place during Scientific Session III on Saturday ... Lumry. The following poster presentation will take place during Poster Session II on Saturday, May 31, ...
Toronto, Ontario--(Newsfile Corp. - May 29, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage ...
CERo Therapeutics Holdings, Inc. (NASDAQ:CERO) has achieved a major milestone in the fight against acute myeloid leukemia ...